87 results on '"Lanctôt, Krista L."'
Search Results
2. Cytochrome P450-soluble epoxide hydrolase oxylipins, depression and cognition in type 2 diabetes
3. The effect of exercise on blood concentrations of angiogenesis markers in older adults: A systematic review and meta-analysis
4. Heterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 Trial
5. Novel fluid biomarkers for mild cognitive impairment: A systematic review and meta-analysis
6. Cytochrome P450-soluble epoxide hydrolase derived linoleic acid oxylipins and cognitive performance in type 2 diabetes
7. Identifying factors influencing cognitive outcomes after anodal transcranial direct current stimulation in older adults with and without cognitive impairment: A systematic review
8. Inflammatory markers in type 2 diabetes with vs. without cognitive impairment; a systematic review and meta-analysis
9. Blood-based biomarkers of agitation in Alzheimer's disease: Advances and future prospects
10. Depression in type 2 diabetes: A systematic review and meta-analysis of blood inflammatory markers
11. Depression and Increased Risk of Alzheimer's Dementia: Longitudinal Analyses of Modifiable Risk and Sex-Related Factors
12. Serum soluble epoxide hydrolase related oxylipins and major depression in patients with type 2 diabetes
13. Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers
14. The association between placebo arm inclusion and adverse event rates in antidepressant randomized controlled trials: An examination of the Nocebo Effect
15. Apathy as a Treatment Target in Alzheimer's Disease: Implications For Clinical Trials
16. Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate
17. Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments
18. Criteria for Psychosis in Major and Mild Neurocognitive Disorders: International Psychogeriatric Association (IPA) Consensus Clinical and Research Definition
19. Serum osteocalcin is associated with subjective stress in people with depression and type 2 diabetes
20. Antidepressant-placebo differences for specific adverse events in major depressive disorder: A systematic review
21. Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease
22. Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial
23. The Roles of Apathy and Depression in Predicting Alzheimer Disease: A Longitudinal Analysis in Older Adults With Mild Cognitive Impairment
24. Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need
25. Longitudinal associations between 4-hydroxynonenal and depression in coronary artery disease patients
26. The effect of exercise on resting concentrations of peripheral brain-derived neurotrophic factor (BDNF) in major depressive disorder: A meta-analysis
27. Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review
28. Global grey matter volume in adult bipolar patients with and without lithium treatment: A meta-analysis
29. Update on the Risk of Motor Vehicle Collision or Driving Impairment with Dementia: A Collaborative International Systematic Review and Meta-Analysis
30. Peripheral lipid oxidative stress markers are related to vascular risk factors and subcortical small vessel disease
31. Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms
32. Ceramides and depression: A systematic review
33. Oxidative stress predicts depressive symptom changes with omega-3 fatty acid treatment in coronary artery disease patients
34. Apathy associated with neurocognitive disorders: Recent progress and future directions
35. Suicide in males and females with cardiovascular disease and comorbid depression
36. A Randomized Placebo-Controlled Discontinuation Study of Cholinesterase Inhibitors in Institutionalized Patients With Moderate to Severe Alzheimer Disease
37. White Matter Microstructural Integrity Is Associated with Executive Function and Processing Speed in Older Adults with Coronary Artery Disease
38. Predictors of readmission to a psychiatry inpatient unit
39. Platelet activating factors in depression and coronary artery disease: A potential biomarker related to inflammatory mechanisms and neurodegeneration
40. Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future
41. Potential roles of zinc in the pathophysiology and treatment of major depressive disorder
42. Designing a Trial to Evaluate Potential Treatments for Apathy in Dementia: The Apathy in Dementia Methylphenidate Trial (ADMET)
43. Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia
44. Interleukin-17 in post-stroke neurodegeneration
45. Computerized cognitive testing for patients with multiple sclerosis
46. Serotonergic Function and Treatment of Behavioral and Psychological Symptoms of Frontotemporal Dementia
47. Examining the sex-specific association between APOE ε4 status and increased neuropsychiatric symptom burden in populations at risk for Alzheimer's disease
48. Indoleamine 2,3-dioxygenase activation and depressive symptoms in patients with coronary artery disease
49. Apathy Associated with Alzheimer Disease: Use of Dextroamphetamine Challenge
50. A functional neuroimaging study of appetite loss in Alzheimer’s disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.